- Drugs
- Friday, 15 May 2020
Sanofi says COVID-19 vaccine will be available globally at the same time
Sanofi will ensure that a potential vaccine against COVID-19, if approved, reaches all regions of the world at the same time, the chairman of the French drugmaker said on Thursday.
“There will be no particular advance given to any country,” Serge Weinberg told France 2 television.
“We are organised with several manufacturing units. Some of them are in the United States but even more of them are in Europe and France,” he said.
Sanofi operates 73 industrial locations in 32 countries. There is no vaccine approved yet against COVID-19, the illness caused by the new coronavirus.
The group’s chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world, after angering the French government earlier by saying the United States would get priority access.
Related Industry Updates
Caldolor® Demonstrates Favorable Safety Profile In Newborns
Mar 17, 2020
Monoclonal Antibody Therapeutics (mABs) Market is expected to reach US$ 542.80 billion by 2030
Feb 05, 2024
Stomach Cancer Market is expected to reach US$ 10,751.42 million by 2030
Dec 28, 2023
Hyperpigmentation Disorder Treatment Market is expected to reach US$ 11.78 billion by 2030
Feb 16, 2024
Investors Hunting for Winners in Ashes of Industry Fire up Rally in Cannabis Stocks
Jan 24, 2020
Hikma receives FDA approval for its generic Vascepa®
May 22, 2020
United Cannabis Corporation Receives Notice of Allowance for New Patent Covering Methods of Preparing and Using Cannabinoid Formulations
Dec 12, 2019
Follow us on
